NPPB and atrial fibrillation: Regarding biomarkers for AF, guidelines for patient management have shown that serum N-terminal prohormone B-type natriuretic peptide (NT-proBNP) is a more powerful biomarker than other clinical variables, as well as echocardiographic assessment (left atrial and ventricular diameters) [2].